ATE480774T1 - Verfahren und proben zur detektion des tumor spezifische fusion proteinen - Google Patents

Verfahren und proben zur detektion des tumor spezifische fusion proteinen

Info

Publication number
ATE480774T1
ATE480774T1 AT03772958T AT03772958T ATE480774T1 AT E480774 T1 ATE480774 T1 AT E480774T1 AT 03772958 T AT03772958 T AT 03772958T AT 03772958 T AT03772958 T AT 03772958T AT E480774 T1 ATE480774 T1 AT E480774T1
Authority
AT
Austria
Prior art keywords
fusion proteins
samples
tumor specific
specific fusion
detecting tumor
Prior art date
Application number
AT03772958T
Other languages
English (en)
Inventor
Dongen Jacobus Van
Original Assignee
Univ Erasmus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Erasmus filed Critical Univ Erasmus
Application granted granted Critical
Publication of ATE480774T1 publication Critical patent/ATE480774T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mathematical Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT03772958T 2002-11-07 2003-11-06 Verfahren und proben zur detektion des tumor spezifische fusion proteinen ATE480774T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02079666 2002-11-07
PCT/NL2003/000776 WO2004042398A1 (en) 2002-11-07 2003-11-06 Method and probes for the detection of a tunor specific fusion protein

Publications (1)

Publication Number Publication Date
ATE480774T1 true ATE480774T1 (de) 2010-09-15

Family

ID=32309413

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03772958T ATE480774T1 (de) 2002-11-07 2003-11-06 Verfahren und proben zur detektion des tumor spezifische fusion proteinen

Country Status (13)

Country Link
US (2) US7575874B2 (de)
EP (1) EP1565746B1 (de)
JP (1) JP4594733B2 (de)
CN (1) CN1735805A (de)
AT (1) ATE480774T1 (de)
AU (1) AU2003279618B2 (de)
CA (1) CA2505509C (de)
DE (1) DE60334144D1 (de)
DK (1) DK1565746T3 (de)
ES (1) ES2352050T3 (de)
NZ (1) NZ540218A (de)
PT (1) PT1565746E (de)
WO (1) WO2004042398A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4594733B2 (ja) 2002-11-07 2010-12-08 エラスムス ユニフェルシテイト ロッテルダム 腫瘍特異的融合蛋白質の検出のための方法およびプローブ
JP2007040834A (ja) * 2005-08-03 2007-02-15 Japan Science & Technology Agency 免疫測定用試薬
US8124351B2 (en) 2005-11-18 2012-02-28 Board Of Regents, The University Of Texas System Quantification of fusion proteins and their activity from chromosomal translocation
US8134743B2 (en) * 2007-07-18 2012-03-13 Xerox Corporation Methods and systems for routing and processing jobs in a production environment
US20110229415A1 (en) * 2007-08-06 2011-09-22 Sylvia Daunert Semi-synthetic antibodies as recognition elements
BRPI0819739A2 (pt) * 2007-11-21 2017-05-09 Univ Erasmus Med Ct Rotterdam sondas de fret otimizadas e usos das mesmas
WO2012057689A1 (en) * 2010-10-29 2012-05-03 Ge Healthcare Bio-Sciences Ab Proximity ligation technology for western blot applications
US9823246B2 (en) 2011-12-28 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Fluorescence enhancing plasmonic nanoscopic gold films and assays based thereon
CN104155452A (zh) * 2013-05-15 2014-11-19 复旦大学 一种检测细胞内蛋白质降解的方法
EP3213080B1 (de) * 2014-10-30 2019-04-24 Erasmus University Medical Center Rotterdam Reagenzien, verfahren und kits zur diagnose primärer immunschwächen
US20160146799A1 (en) * 2014-11-05 2016-05-26 Nirmidas Biotech, Inc. Metal composites for enhanced imaging
CN106124500B (zh) * 2016-08-29 2019-09-03 华北理工大学 一种用菁染料可视化识别转铁蛋白的方法
EP3592373A4 (de) * 2017-03-09 2021-01-20 Shriners Hospitals for Children Kollagenassays vom typ x und verfahren zu ihrer verwendung
CN110407918B (zh) * 2019-07-22 2021-06-18 上海交通大学医学院附属瑞金医院 一种温敏靶向荧光探针及其制备方法和应用
US12252582B2 (en) 2019-08-29 2025-03-18 University Of Delaware Biofunctional thiophene monomers and polymers thereof for electronic biomedical devices

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091206A (en) 1987-10-26 1992-02-25 Baxter Diagnostics Inc. Process for producing magnetically responsive polymer particles and application thereof
WO1992021032A1 (en) 1991-05-24 1992-11-26 The Regents Of The University Of California Methods for the detection of bcr-abl and abnormal abl proteins in leukemia patients
US5514340A (en) 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
US6107457A (en) 1995-02-16 2000-08-22 Board Of Regents, The University Of Texas System Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth
US6159748A (en) 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
US6686165B2 (en) 1997-05-20 2004-02-03 Erasmus Universiteit Rotterdam Recognition of tumor-specific gene products in cancer
ATE261125T1 (de) 1997-05-20 2004-03-15 Univ Erasmus Erkennung von tmorspezifische genprodukte
JP3513068B2 (ja) * 1999-05-12 2004-03-31 浜松ホトニクス株式会社 生細胞の細胞質内標的核酸を検出する方法
AU781992B2 (en) * 2000-04-04 2005-06-23 Medical Research Council Methods involving induced dimerisation by cellular components
WO2002088733A1 (fr) * 2001-04-23 2002-11-07 Eiken Kagaku Kabushiki Kaisha Methode d'analyse faisant intervenir une interaction intermoleculaire par rapporteur (marqueur)
CA2411392C (en) 2001-11-07 2012-10-16 Stemcell Technologies Inc. Tetrameric antibody complexes for blocking non-specific binding of antigens
JP4594733B2 (ja) * 2002-11-07 2010-12-08 エラスムス ユニフェルシテイト ロッテルダム 腫瘍特異的融合蛋白質の検出のための方法およびプローブ
EP1507147A1 (de) 2003-08-12 2005-02-16 Erasmus University Medical Center Rotterdam Verfahren zum Nachweiss von niedrigem Gehalt an Fusionsprotein

Also Published As

Publication number Publication date
DK1565746T3 (da) 2011-01-10
ES2352050T5 (es) 2011-02-15
US20090305305A1 (en) 2009-12-10
US20050260684A1 (en) 2005-11-24
JP2006505774A (ja) 2006-02-16
WO2004042398A1 (en) 2004-05-21
DE60334144D1 (de) 2010-10-21
ES2352050T3 (es) 2011-03-18
CA2505509C (en) 2013-08-20
AU2003279618A1 (en) 2004-06-07
US7993850B2 (en) 2011-08-09
EP1565746B1 (de) 2010-09-08
CN1735805A (zh) 2006-02-15
NZ540218A (en) 2009-03-31
JP4594733B2 (ja) 2010-12-08
PT1565746E (pt) 2010-12-07
US7575874B2 (en) 2009-08-18
AU2003279618B2 (en) 2009-07-16
EP1565746A1 (de) 2005-08-24
CA2505509A1 (en) 2004-05-21

Similar Documents

Publication Publication Date Title
DE60334144D1 (de) Verfahren und proben zur detektion des tumor spezifische fusion proteinen
ATE394677T1 (de) Fret proben und verfahren zur erkennung aufeinander einwirkeneden moleküle
ES2170220T3 (es) Procedimiento para detectar sustancias biologicamente activas.
CO4870792A1 (es) Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata
EP1499885A4 (de) Neue fusionsproteine und molekulare bindungsassays
DK1137943T3 (da) Fremgangsmåde til påvisning af cancer og reagenser
ATE511649T1 (de) Verbesserte fret-sonden und ihre verwendung
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
ATE490466T1 (de) Als interne funktionskontrolle in tests zum nachweis von seltenen zellen verwendete markierte zellen
DK2311934T3 (da) Hurtig påvisning af replicerende celler
WO2007121465A3 (en) Detection of proteins from circulating neoplastic cells
DE69939896D1 (de) Methoden zur detektion von nukleinsäuren unter verwendung von zymogenen und dazugehörige kits
TR199901569T2 (xx) T�berk�lozun te�hisi i�in bile�ikler ve y�ntemler.
SE9500023L (sv) Sätt att detektera cancer
AU2849300A (en) Methods and assay kits for detecting mononuclear cell phenotype
GB2377272A (en) Method and apparatus for DNA sequencing
NO20010362L (no) Nukleinsyrer kodende for proteiner som er involvert i sensorisk transduksjon
ATE286984T1 (de) Methode und testsatz zur detektion von schistosomiasis mittels polymerasekettenreaktion
ATE293707T1 (de) Nukelinsäure primer und proben zum nachweis von tumorzellen
ATE335816T1 (de) Verfahren zum nachweis prokaryontischer dna
DE60010323D1 (de) Fluoreszenzkorrelationsspektroskopie zur identifizierung von verbindung-ziel-bindung
ATE348190T1 (de) Verfahren zum nachweis von protein- proteininteraktionen in membranen
DE60121547D1 (de) Electrochemisches verfahren zum nachweis von nukleinsäuren
ATE432364T1 (de) Sonden zum nachweis von tumorzellen
DE69933774D1 (de) Verbinden einer gensequenz mit einer genfunktion mittels dreidimensionaler (3d) proteinstrukturbestimmung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1565746

Country of ref document: EP